Hosted by The Royal Marsden NHS Foundation Trust
This preceptorship will consider all aspects of solid tumour cell therapy including procurement of starting materials, cell transfer, adjuvant therapy, toxicity management, associated regulation and the contribution of stakeholders from the cell therapy laboratory to critical care. The state of the art will be discussed including the current trial landscape, considering both academic and industry sponsored studies and cutting edge translational data. As we move towards the first possible licensed cell therapy for solid tumours, there will be additional focus on tumour infiltrating lymphocyte therapy, potential models of delivery in the National Health Service and anticipated challenges .
Speakers will include Alison Betof Warner ( USA), Marco Donia Herlev Denmark), Clare Roddie ( London) and Andrew Furness ( London)
Further information and to register (cost £200)